Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BNT116 |
Trade Name | |
Synonyms | BNT-116|BNT 116 |
Drug Descriptions |
BNT116 is composed of liposomal RNAs encoding 6 tumor-associated antigens, which may potentially inhibit tumor growth (Ann Oncol (2022) 33 (suppl_7): S1095). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C201496 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BNT116 | BNT116 | 0 | 1 |
BNT116 + Cemiplimab | BNT116 Cemiplimab | 0 | 2 |
BNT116 + Docetaxel | BNT116 Docetaxel | 0 | 1 |